Savara Inc

NASDAQ:SVRA 12:39:21 PM EDT

1.64

+0.03 (+1.86%)

Savara Inc Stock, NASDAQ:SVRA

6836 Bee Cave Road, Suite 200, Austin, Texas 78746

United States of America

Phone: +1.512.614.1848

Number of Employees: 27

http://www.savarapharma.com

Description

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. The firm's lead program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF, is being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded on April 27, 2017 and is headquartered in Austin, TX.